To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

Bastian Tugemann, Navid Manouchehri, Olaf Stuve

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number103541
JournalMultiple Sclerosis and Related Disorders
StatePublished - Mar 2022

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this